Cost-Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany
Jan Zeidler(Leibniz University Hannover), Stephan Heres(München Klinik), Wolfgang Greiner(Bielefeld University), Jörg Mahlich(University of Vienna)
Cited by 9
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
|The Lancet|2012|923
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476